Phase IV randomized preference study in patients eligible for calcium and vitamin D supplementation

References

• Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: The National Academies Press, 2011
   Google Scholar
• Andersson A, Bjork A, Kristiansson P, et al. Vitamin D intake and status in immigrant and native Swedish women: a study at a primary care centre located at 60°N in Sweden. Food Nutr Res 2013;57:20089
   Web of Science ®Google Scholar
• Rizzoli R, Boonen S, Brandi ML, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 2013;29:305-13
   PubMed Web of Science ®Google Scholar
• Rizzoli R, Stevenson JC, Bauer JM, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas 2014;79:122-32
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Benefit–risk assessment of vitamin D supplementation. Osteoporos Int 2010;21:1121-32
   PubMed Web of Science ®Google Scholar
• Prentice RL, Pettinger MB, Jackson RD, et al. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int 2013;24:567-80
   PubMed Web of Science ®Google Scholar
• Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370:657-66
   PubMed Web of Science ®Google Scholar
• Pfeifer M, Begerow B, Minne HW, et al. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009;20:315-22
   PubMed Web of Science ®Google Scholar
• Chung M, Lee J, Terasawa T, et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011;155:827-38
   PubMed Web of Science ®Google Scholar
• The DIPART (vitamin D Individual Patient Analysis of Randomised Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010;340:b5463
   Google Scholar
• Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-8
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Leung W, Tai V, et al. Calcium intake and risk of fracture: systematic review. BMJ 2015;351:h4580
   PubMed Web of Science ®Google Scholar
• Tai V, Leung W, Grey A, et al. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ 2015;351:h4183
   PubMed Web of Science ®Google Scholar
• Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014;4:CD000227
   PubMed Web of Science ®Google Scholar
• Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013;24:23-57
   PubMed Web of Science ®Google Scholar
• Hiligsmann M, Ben Sedrine W, Bruyere O, et al. Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis. Eur J Public Health 2015;25:20-5
   PubMed Web of Science ®Google Scholar
• Boonen S, Bischoff-Ferrari HA, Cooper C, et al. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int 2006;78:257-70
   PubMed Web of Science ®Google Scholar
• Rozenberg S, Body JJ, Bruyere O, et al. Effects of dairy products consumption on health: benefits and beliefs – a commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. Calcif Tissue Int 2016;98:1-17
   PubMed Web of Science ®Google Scholar
• Ethgen O, Hiligsmann M, Burlet N, et al. Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures. Osteoporos Int 2016;27:301-8
   PubMed Web of Science ®Google Scholar
• Ethgen O, Hiligsmann M, Burlet N, et al. Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures. Arch Public Health 2015;73:48
   PubMed Web of Science ®Google Scholar
• Compston JE, Seeman E. Compliance with osteoporosis therapy is the weakest link. Lancet 2006;368:973-4
   PubMed Web of Science ®Google Scholar
• Siris ES, Selby PL, Saag KG, et al. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med 2009;122:S3-13
   PubMed Web of Science ®Google Scholar
• Hiligsmann M, McGowan B, Bennett K, et al. The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland. Value Health 2012;15:604-12
   PubMed Web of Science ®Google Scholar
• Rees TP, Howe I. A randomised, single-blind, crossover comparison of the acceptability of the calcium and vitamin D3 supplements Calcichew D3 Forte and Ad Cal D3 in elderly patients. Curr Med Res Opin 2001;16:245-51
   PubMed Web of Science ®Google Scholar
• den Uyl D, Geusens PP, van Berkum FN, et al. Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial. Clin Rheumatol 2010;29:465-72
   PubMed Web of Science ®Google Scholar
• Reginster JY, Kaufman JM, Gangjii V. Preference for and acceptability of two formulations of a dietary supplement containing calcium plus vitamin D3: a randomized, open-label, crossover trial in adult patients with calcium and vitamin D deficiencies. Curr Ther Res Clin Exp 2005;66:23-34
   PubMed Web of Science ®Google Scholar
• McCombs JS, Thiebaud P, McLaughlin-Miley C, et al. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004;48:271-87
   PubMed Web of Science ®Google Scholar
• Rossini M, Bianchi G, Di Munno O, et al. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 2006;17:914-21
   PubMed Web of Science ®Google Scholar
• Cortet B, Benichou O. Adherence, persistence, concordance: do we provide optimal management to our patients with osteoporosis? Joint Bone Spine 2006;73:e1-7
   PubMedGoogle Scholar
• van den Boogaard CH, Breekveldt-Postma NS, Borggreve SE, et al. Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study. Curr Med Res Opin 2006;22:1757-64
   PubMed Web of Science ®Google Scholar
• Tafaro L, Nati G, Leoni E, et al. Adherence to anti-osteoporotic therapies: role and determinants of “spot therapy”. Osteoporos Int 2013;24:2319-23
   PubMed Web of Science ®Google Scholar
• Brun J. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study. J Int Med Res 1994;22:266-72
   PubMed Web of Science ®Google Scholar
• Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-17
   PubMed Web of Science ®Google Scholar
• Tosteson AN, Grove MR, Hammond CS, et al. Early discontinuation of treatment for osteoporosis. Am J Med 2003;115:209-16
   PubMed Web of Science ®Google Scholar
• Zafran N, Liss Z, Peled R, et al. Incidence and causes for failure of treatment of women with proven osteoporosis. Osteoporos Int 2005;16:1375-83
   PubMed Web of Science ®Google Scholar